Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.25.0.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 864,840 $ 3,483,501
Prepaid expenses and other current assets 607,670 382,273
Total current assets 1,472,510 3,865,774
Prepaid research and development expense 1,090,750
Operating lease right-of-use assets 9,811
Total assets 1,472,510 4,966,335
Current liabilities:    
Accounts payable and accrued expenses 1,355,867 1,475,667
Short-term notes payable 328,528 312,703
Operating lease liabilities 9,811
Total current liabilities 1,684,395 1,798,181
Shareholders’ (deficit) equity:    
Preferred stock, no par value; 50,000,000 shares authorized; -0- and 5,417,000 Series A shares, -0- and 4,050,000 Series B shares, -0- and -0- Series C shares, 7,488,692 and 7,488,692 Series F shares outstanding at December 31, 2024 and December 31, 2023, respectively 1,592,723
Common stock, $0.001 par value; 350,000,000 shares authorized; 12,570,100 and 3,080,693 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively 12,570 3,081
Additional paid-in capital 216,561,717 207,790,604
Accumulated Deficit (216,786,172) (206,218,254)
Total shareholders’ (deficit) equity (211,885) 3,168,154
Total liabilities and shareholders’ (deficit) equity $ 1,472,510 $ 4,966,335